基因组资料及其与宫癌临床特征和免疫特征的关系

Zinan Lu1, Peiwen Fan2, Wen Huo1

  • 1Xinjiang Medical University Affiliated Tumor Hospital, Key Laboratory of Cancer Immunotherapy and Radiotherapy, Chinese Academy of Medical Sciences, Urumqi, Xinjiang 830011, China; Key Laboratory of Oncology of Xinjiang Uyghur Autonomous Region, Urumqi, Xinjiang 830011, China.

PubMed
概括

这项研究分析了宫癌的基因组变化,发现了AR和KMT2D等关键基因突变. 它确定了BMI和特定的基因突变作为生存的预测因素,并揭示了某些患者群体的免疫检查点基因上调.